Lawrence Leung

6.0k total citations
113 papers, 4.8k citations indexed

About

Lawrence Leung is a scholar working on Hematology, Molecular Biology and Cancer Research. According to data from OpenAlex, Lawrence Leung has authored 113 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Hematology, 33 papers in Molecular Biology and 26 papers in Cancer Research. Recurrent topics in Lawrence Leung's work include Blood Coagulation and Thrombosis Mechanisms (40 papers), Platelet Disorders and Treatments (28 papers) and Protease and Inhibitor Mechanisms (25 papers). Lawrence Leung is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (40 papers), Platelet Disorders and Treatments (28 papers) and Protease and Inhibitor Mechanisms (25 papers). Lawrence Leung collaborates with scholars based in United States, France and Japan. Lawrence Leung's co-authors include Ralph L. Nachman, John Morser, Timothy Myles, P C Harpel, Roy L. Silverstein, Xiaoyan Du, Lei Zhao, Craig S. Gibbs, Toshihiko Nishimura and Linda C. Griffin and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Lawrence Leung

106 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lawrence Leung United States 44 1.9k 1.6k 822 659 631 113 4.8k
Henri H. Versteeg Netherlands 37 2.4k 1.2× 1.7k 1.1× 706 0.9× 1.1k 1.7× 755 1.2× 129 7.1k
M. Anna Kowalska United States 37 2.0k 1.0× 1.3k 0.8× 480 0.6× 1.3k 1.9× 453 0.7× 113 4.9k
Matthew J. Flick United States 41 2.3k 1.2× 1.8k 1.1× 1.6k 1.9× 932 1.4× 1.4k 2.3× 120 7.2k
Harry F.G. Heijnen Netherlands 33 1.4k 0.7× 3.7k 2.4× 1.4k 1.6× 1.1k 1.7× 574 0.9× 58 6.3k
Osamu Matsuo Japan 34 1.2k 0.6× 1.4k 0.9× 1.6k 2.0× 293 0.4× 763 1.2× 269 4.3k
Barbara Ferris United States 28 1.1k 0.6× 2.4k 1.5× 687 0.8× 705 1.1× 717 1.1× 39 4.6k
H.R. Lijnen Belgium 44 1.8k 0.9× 1.5k 1.0× 2.7k 3.3× 456 0.7× 1.2k 1.9× 147 5.5k
Ewa Paleolog United Kingdom 46 829 0.4× 2.3k 1.5× 989 1.2× 1.5k 2.3× 396 0.6× 123 6.6k
Elisabeth M. Cramer France 38 2.6k 1.4× 1.3k 0.8× 252 0.3× 1.1k 1.6× 925 1.5× 119 5.1k
David H. Lovett United States 50 693 0.4× 2.5k 1.6× 1.8k 2.2× 1.0k 1.6× 563 0.9× 126 6.6k

Countries citing papers authored by Lawrence Leung

Since Specialization
Citations

This map shows the geographic impact of Lawrence Leung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Leung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Leung more than expected).

Fields of papers citing papers by Lawrence Leung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Leung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Leung. The network helps show where Lawrence Leung may publish in the future.

Co-authorship network of co-authors of Lawrence Leung

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Leung. A scholar is included among the top collaborators of Lawrence Leung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Leung. Lawrence Leung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Lei, Fahim Abbasi, Mohsen Fathzadeh, et al.. (2024). Chemerin in Participants with or without Insulin Resistance and Diabetes. Biomedicines. 12(4). 924–924. 5 indexed citations
2.
Zhou, Qi, Lei Zhao, Toshihiko Nishimura, et al.. (2022). Thrombin cleavage of osteopontin initiates osteopontin’s tumor‐promoting activity. Journal of Thrombosis and Haemostasis. 20(5). 1256–1270. 18 indexed citations
3.
Zhao, Lei, et al.. (2021). Both plasma basic carboxypeptidases, carboxypeptidase B2 and carboxypeptidase N, regulate vascular leakage activity in mice. Journal of Thrombosis and Haemostasis. 20(1). 238–244. 2 indexed citations
4.
Tardelli, Matteo, Angelika Neuhofer, Gerhard Prager, et al.. (2019). Antibody-mediated targeting of cleavage-specific OPN-T cell interactions. PLoS ONE. 14(4). e0214938–e0214938. 3 indexed citations
6.
Nishimura, Toshihiko, et al.. (2015). Carboxypeptidase B2 deficiency reveals opposite effects of complement C3a and C5a in a murine polymicrobial sepsis model. Journal of Thrombosis and Haemostasis. 13(6). 1090–1102. 26 indexed citations
7.
Yamaguchi, Yasuto, Xiaoyan Du, Lei Zhao, John Morser, & Lawrence Leung. (2011). Proteolytic Cleavage of Chemerin Protein Is Necessary for Activation to the Active Form, Chem157S, Which Functions as a Signaling Molecule in Glioblastoma. Journal of Biological Chemistry. 286(45). 39510–39519. 64 indexed citations
8.
Wang, Chieh‐Huei, Xiaoyan Du, Chia‐Yi Lin, et al.. (2009). Thrombospondin type I domain containing 7A (THSD7A) mediates endothelial cell migration and tube formation. Journal of Cellular Physiology. 222(3). 685–694. 67 indexed citations
9.
Leung, Lawrence, Timothy Myles, Toshihiko Nishimura, Jason Jungsik Song, & William H. Robinson. (2008). Regulation of tissue inflammation by thrombin-activatable carboxypeptidase B (or TAFI). Molecular Immunology. 45(16). 4080–4083. 62 indexed citations
10.
Tibayan, Frederick A., Lawrence Leung, Thomas A. Burdon, & James I. Fann. (2008). Heparin-induced thrombosis without thrombocytopenia. Journal of Thoracic and Cardiovascular Surgery. 139(2). e6–e7. 4 indexed citations
11.
Zhang, Weiqing, Yung‐Jen Chuang, Richard Swanson, et al.. (2006). Antiangiogenic Antithrombin Induces Global Changes in the Gene Expression Profile of Endothelial Cells. Cancer Research. 66(10). 5047–5055. 27 indexed citations
12.
Nishimura, Toshihiko, et al.. (2006). Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo. Blood. 109(5). 1992–1997. 43 indexed citations
13.
Leung, Lawrence. (2006). Perioperative Evaluation of Bleeding Diathesis. Hematology. 2006(1). 457–461. 28 indexed citations
14.
Ishida, Tatsuro, Zhi Zheng, Helén L. Dichek, et al.. (2003). Molecular cloning of nonsecreted endothelial cell-derived lipase isoforms. Genomics. 83(1). 24–33. 9 indexed citations
15.
Ng, Daniel K., et al.. (2000). A randomized controlled trial of azithromycin and amoxycillin/clavulanate in the management of subacute childhood rhinosinusitis. Journal of Paediatrics and Child Health. 36(4). 378–381. 8 indexed citations
16.
Leung, Lawrence & Scott W. Hall. (2000). Dissociation of Thrombin's Substrate Interactions Using Site-Directed Mutagenesis. Trends in Cardiovascular Medicine. 10(2). 89–92. 8 indexed citations
17.
Murphy, Joseph F., John L. McGregor, & Lawrence Leung. (1998). Senescent human neutrophil binding to thrombospondin (TSP): evidence for a TSP‐independent pathway of phagocytosis by macrophages. British Journal of Haematology. 102(4). 957–964. 12 indexed citations
18.
Kaplan, Aaron V., et al.. (1991). Argatrobin reduces platelet deposition at the site of balloon angioplasty in an ex vivowhole artery model. Journal of the American College of Cardiology. 17(2). A144–A144. 1 indexed citations
19.
Saigo, Katsuyasu, et al.. (1990). Histidine‐rich glycoprotein as a negative acute phase reactant. American Journal of Hematology. 34(2). 149–150. 31 indexed citations
20.
Polley, Margaret J., et al.. (1981). Thrombin-induced platelet membrane glycoprotein IIb and IIIa complex formation. An electron microscope study.. The Journal of Experimental Medicine. 154(4). 1058–1068. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026